Literature DB >> 22269886

Seroprevalence of hepatitis E antibodies and risk profile of HEV seropositivity in The Netherlands, 2006-2007.

L Verhoef1, M Koopmans, E Duizer, J Bakker, J Reimerink, W Van Pelt.   

Abstract

SHepatitis E virus (HEV) is now considered an endemic pathogen in industrialized countries, leading to acute and sometimes chronic hepatitis, mostly in vulnerable people. The endemic sources are unclear. A survey in The Netherlands in 2006-2007 showed a 1·9% seroprevalence of HEV antibodies measured by ELISA and confirmed by immunoblot in a nationwide sample. Overall, in 134/7072 (1·9%) seropositive individuals, older age (P<0·01), being male (P<0·01), working with patients (P=0·03), working with animals (P=0·07), recent diarrhoeal complaints (P=0·07) and adhering to a religion that considers pigs unclean (P<0·01) were independently associated with seropositivity in multivariate analysis. Sub-analysis of 59/4022 (1·5%) anti-HEV antibody-positive subjects with probable endemic exposure showed independent association with youngest household member being aged <5 years or between 19 and <65 years (P=0·05) in multivariate analysis. These findings may contribute to a better understanding of the sources of endemic HEV exposure, and also highlight the need for systematic epidemiological and serological evaluation of new cases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269886     DOI: 10.1017/S0950268811002913

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  16 in total

1.  Prevalence of Hepatitis E Virus among Adults in South-West of Iran.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Manoochehr Makvandi
Journal:  Hepat Res Treat       Date:  2015-06-23

Review 2.  Autochthonous Hepatitis E Virus Infection in Europe: A Matter of Concern for Public Health?

Authors:  José-Manuel Echevarría
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

Review 3.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

4.  Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006.

Authors:  Zhiyuan Jia; Yao Yi; Jianhua Liu; Jingyuan Cao; Yong Zhang; Ruiguang Tian; Tao Yu; Hao Wang; Xinying Wang; Qiudong Su; Wenting Zhou; Fuqiang Cui; Xiaofeng Liang; Shengli Bi
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

5.  Hepatitis E virus seroprevalence among the general population in a livestock-dense area in the Netherlands: a cross-sectional population-based serological survey.

Authors:  Arianne B van Gageldonk-Lafeber; Wim van der Hoek; Floor Borlée; Dick J J Heederik; Sofie H Mooi; Catharina B M Maassen; C Joris Yzermans; Barry Rockx; Lidwien A M Smit; Johan H J Reimerink
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

6.  A cross-sectional study among Polish hunters: seroprevalence of hepatitis E and the analysis of factors contributing to HEV infections.

Authors:  Anna Baumann-Popczyk; Bartłomiej Popczyk; Elżbieta Gołąb; Wioletta Rożej-Bielicka; Małgorzata Sadkowska-Todys
Journal:  Med Microbiol Immunol       Date:  2017-08-03       Impact factor: 3.402

7.  Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.

Authors:  Li Zhang; Zechun Jiang; Jingjing Lv; Jiaye Liu; Bingyu Yan; Yi Feng; Li Li; Guomin Zhang; Fuzhen Wang; Aiqiang Xu
Journal:  BMC Infect Dis       Date:  2018-02-12       Impact factor: 3.090

8.  Hepatitis E Virus (HEV) seroprevalence in the general population of the Republic of Korea in 2007-2009: a nationwide cross-sectional study.

Authors:  Youngsil Yoon; Hye Sook Jeong; Haesun Yun; Hyeokjin Lee; Yoo-Sung Hwang; Bohyun Park; Chae Jin Lee; Sangwon Lee; Ji-Yeon Hyeon
Journal:  BMC Infect Dis       Date:  2014-09-24       Impact factor: 3.090

9.  Past and present of hepatitis E in the Netherlands.

Authors:  Boris M Hogema; Michel Molier; Ed Slot; Hans L Zaaijer
Journal:  Transfusion       Date:  2014-05-29       Impact factor: 3.157

10.  A Public Health initiative on hepatitis E virus epidemiology, safety and control in Portugal--study protocol.

Authors:  João R Mesquita; Mette Myrmel; Kathrine Stene-Johansen; Joakim Øverbø; Maria S J Nascimento
Journal:  BMC Infect Dis       Date:  2016-01-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.